Buscar
-
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
(The Lancet. vol. 403, n° 10432, pp. 1141-1152, 2024-03-07)Article de revue -
Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis
(Journal of Clinical Medicine. vol. 11, n° 7, 2022-03-25)Article de revueLibre acceso -
Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus
(Current Opinion in Ophthalmology. vol. 34, n° 5, pp. 403-413, 2023-09-01)Article de revueLibre acceso -
TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration
(Ophthalmology Science. vol. 1, n° 4, 2021-12)Article de revueLibre acceso -
Microperimetry to predict disease progression in eyes at high risk of age-related macular degeneration disease: The PREVISION study
(Acta Ophthalmologica. vol. 101, n° 2, pp. e135-e142, 2023-03)Article de revueLibre acceso -
XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration
(Ophthalmology and Therapy. vol. 13, n° 3, pp. 725-738, 2024-03-01)Article de revueLibre acceso -
Retinal microvasculature and incident dementia over 10 years: The Three-City-Alienor cohort
(Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. vol. 15, n° 4, pp. e12480, 2023-10)Article de revueLibre acceso -
Age-related macular degeneration and loss of autonomy : the Alienor-3C Study
Communication dans un congrès -
Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data
(Journal of Medical Economics. vol. 24, n° 1, pp. 1-37, 2021-08-23)Article de revueLibre acceso -
Association of Age-Related Macular Degeneration with a Blood Biomarker of Lipopolysaccharide, a Gut Bacterial Proinflammatory Toxin
(Investigative Ophtalmology & Visual Science. vol. 64, n° 14, pp. 47, 2023-11-01)Article de revueLibre acceso